©2024 Stanford Medicine
Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors
Not Recruiting
Trial ID: NCT01663363
Purpose
The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and
effective for the correction of myopic refractive errors.
Official Title
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser
Stanford Investigator(s)
Edward Manche, MD
Professor of Ophthalmology
Eligibility
Inclusion Criteria:
- 18 years of age or greater
- Best Spectacle Corrected Visual Acuity (BSCVA) of 20/20 or better
- Uncorrected visual acuity (UCVA) of 20/40 or worse
- Less than 0.75D difference between cycloplegic and manifest refraction sphere.
- Demonstration of refractive stability
- Anticipated post-operative stromal bed thickness of at least 250 microns
- Willing and capable of returning for follow-up examinations for the duration of the
study.
Exclusion Criteria:
- Women who are pregnant, breast-feeding, or intend to become pregnant over the course
of the study
- Concurrent use of topical or systemic medications that may impair healing
- History of any medical conditions that could affect wound healing
- History of prior intraocular or corneal surgery, active ophthalmic disease, or other
ocular abnormality
- Evidence of keratoconus, corneal irregularity, or abnormal topography in the operative
eye(s)
- Known sensitivity or inappropriate responsiveness to any of the medications used in
the post-operative course
Intervention(s):
device: LASIK correction of myopic refractive errors
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305